某院2001～2006年抗肿瘤辅助药利用分析

Utilization of Antineoplastic Assistant Drugs in Our Hospital from 2001 to 2006

目的:评价甘肃省肿瘤医院抗肿瘤辅助药的临床应用情况及趋势。方法:对甘肃省肿瘤医院2001～2006年抗肿瘤辅助药的品种、剂型、销售金额、用药频度(DDDs)等进行统计、分析。结果:除2001年外,该院抗肿瘤辅助药的品种及销售金额呈逐年上升趋势,抗肿瘤中药、西药、生物制品是其主要类型。中药销售金额连续5年位居榜首,抗肿瘤中药、其它类辅助药、止吐药、升白药DDDs靠前;抗肿瘤辅助药以国产注射荆为主。结论:该院抗肿瘤辅助药用量快速增长,其使用基本合理,但仍需加强管理。

OBJECTIVE： To evaluate the status quo and the trend of the clinical utilization of antineoplastic assistant drugs in our hospital. METHODS： The utilization of antineoplastic assistant drugs in our hospital between 2001 and 2006 was analyzed statistically in respect of the drug kinds, dosage form, consumption sum and DDDs etc. RESULTS： Both the number of kinds and the consumption sum of antineoplastic assistant drugs increased year on year from 2002 to 2006 （except in 2001） Chinese traditional drugs, western medicines and biological products were the top three categories of all the antineoplastic assistant drugs used in our hospital. In terms of consumption sum, Chinese traditional drugs had dominated the first place over the five consecutive years. In terms of DDDs, traditional Chinese antineoplastic drugs, other kinds of antineoplastic adjuvant drugs, antivomit drugs, Shengbaiyao （increasing the number of leucocytes） took the lead. Of all the antineoplastic assistant drugs used, domestic injections took the lead. CONCLUSION： The utilization of the antineoplastic assistant drugs in our hospital was rational on the whole yet the consumption of which increased rapidly, thus strengthened management on which is still needed.